Khasabova IA et al. |
JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy. |
2014 |
Pharmacol. Res. |
pmid:25304184
|
Mulè F et al. |
Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations. |
2007 |
Pharmacol. Res. |
pmid:17656103
|
Navarria A et al. |
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis. |
2014 |
Pharmacol. Res. |
pmid:24861565
|
Kerr DM et al. |
Pharmacological inhibition of fatty acid amide hydrolase attenuates social behavioural deficits in male rats prenatally exposed to valproic acid. |
2016 |
Pharmacol. Res. |
pmid:27592249
|
Yousif MH and Oriowo MA |
Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments. |
1999 |
Pharmacol. Res. |
pmid:10527656
|
Spradley JM et al. |
Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms. |
2010 |
Pharmacol. Res. |
pmid:20416378
|
Guindon J et al. |
Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment. |
2013 |
Pharmacol. Res. |
pmid:23127915
|
De Petrocellis L et al. |
N-palmitoyl-vanillamide (palvanil) is a non-pungent analogue of capsaicin with stronger desensitizing capability against the TRPV1 receptor and anti-hyperalgesic activity. |
2011 |
Pharmacol. Res. |
pmid:21215315
|
Malek N et al. |
The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain. |
2016 |
Pharmacol. Res. |
pmid:27326920
|
Fowler CJ and Ghafouri N |
Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake? |
2008 |
Pharmacol. Res. |
pmid:18675915
|
Nicolussi S et al. |
Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice. |
2014 |
Pharmacol. Res. |
pmid:24412246
|
Khasabova IA et al. |
Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain. |
2011 |
Pharmacol. Res. |
pmid:21440630
|
Baranowska-Kuczko M et al. |
Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery. |
2012 |
Pharmacol. Res. |
pmid:22627170
|
Snider NT et al. |
Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications. |
2010 |
Pharmacol. Rev. |
pmid:20133390
|
Blankman JL and Cravatt BF |
Chemical probes of endocannabinoid metabolism. |
2013 |
Pharmacol. Rev. |
pmid:23512546
|
Starowicz K et al. |
Biochemistry and pharmacology of endovanilloids. |
2007 |
Pharmacol. Ther. |
pmid:17349697
|
Burstein SH |
The cannabinoid acids: nonpsychoactive derivatives with therapeutic potential. |
1999 |
Pharmacol. Ther. |
pmid:10341359
|
Porter AC and Felder CC |
The endocannabinoid nervous system: unique opportunities for therapeutic intervention. |
2001 |
Pharmacol. Ther. |
pmid:11448725
|
Woodward DF et al. |
The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products. |
2008 |
Pharmacol. Ther. |
pmid:18700152
|
McFarland MJ and Barker EL |
Anandamide transport. |
2004 |
Pharmacol. Ther. |
pmid:15518883
|